Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Division of Hematology & Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA.
Sci Transl Med. 2024 Oct 23;16(770):eado5108. doi: 10.1126/scitranslmed.ado5108.
After allogeneic hematopoietic cell transplantation (HCT), a very small number of donor stem cells reconstitute the recipient hematopoietic system, whereas the donor is left with a near-normal pool of stem cells. We hypothesized that the increased replicative stress on transplanted donor cells in the recipient could lead to the disproportionate proliferation of clonal hematopoiesis (CH) variants. We obtained blood samples from 16 related donor-recipient pairs at a median of 33.8 years (range: 6.6 to 45.7) after HCT, including the longest surviving HCT recipients in the world. For 11 of 16 pairs, a donor sample from the time of HCT was available for comparison. We performed ultrasensitive duplex sequencing of genes recurrently mutated in myeloid malignancies and CH, as well as a set of functionally neutral genomic regions representative of human genomic content at large. CH variants were observed in all donors, even those as young as 12 years old. Where donor pre-HCT sample was available, the average mutation rate in donors compared to recipients post-HCT was similar (2.0% versus 2.6% per year, respectively) within genes recurrently mutated in myeloid malignancies. Twenty-two (5.6%) of the 393 variants shared between paired donors and recipients post-HCT showed ≥10-fold higher variant allele frequency (VAF) in the recipient. A longer time since HCT was positively associated with the expansion of shared variant VAFs in the recipient. In conclusion, even decades after HCT, there does not appear to be widespread accelerated clonal expansion in the transplanted cells, highlighting the immense regenerative capacity of the human hematopoietic system.
在异基因造血细胞移植(HCT)后,极少数供体干细胞重建受者造血系统,而供体则保留了近乎正常的干细胞池。我们假设,受者中移植供体细胞的复制应激增加,可能导致克隆性造血(CH)变体的不成比例增殖。我们从 16 对相关供体-受者在 HCT 后中位数为 33.8 年(范围:6.6 至 45.7)的时间点获得了血液样本,包括世界上存活时间最长的 HCT 受者。对于 16 对中的 11 对,有供体在 HCT 时的样本可供比较。我们对经常在髓系恶性肿瘤和 CH 中发生突变的基因以及一组代表人类基因组大部分内容的功能中性基因组区域进行了超灵敏双等位基因测序。在所有供体中均观察到 CH 变体,即使是年龄最小的 12 岁的供体。在有供体预 HCT 样本的情况下,供体与 HCT 后受者之间每年在髓系恶性肿瘤中经常发生突变的基因中的突变率相似(分别为 2.0%和 2.6%)。在 HCT 后配对供体和受者之间共享的 393 个变体中,有 22 个(5.6%)的变体等位基因频率(VAF)在受者中高出 10 倍以上。HCT 后时间越长,受者中共享变体 VAF 的扩张呈正相关。总之,即使在 HCT 后几十年,移植细胞中似乎也没有广泛的克隆性扩张加速,这突显了人类造血系统的巨大再生能力。